Anwar Murtaza

971 total citations
13 papers, 596 citations indexed

About

Anwar Murtaza is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Anwar Murtaza has authored 13 papers receiving a total of 596 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 5 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in Anwar Murtaza's work include T-cell and B-cell Immunology (4 papers), Immune Cell Function and Interaction (4 papers) and Vagus Nerve Stimulation Research (2 papers). Anwar Murtaza is often cited by papers focused on T-cell and B-cell Immunology (4 papers), Immune Cell Function and Interaction (4 papers) and Vagus Nerve Stimulation Research (2 papers). Anwar Murtaza collaborates with scholars based in United States, Germany and United Kingdom. Anwar Murtaza's co-authors include Vijay K. Kuchroo, Lindsay B. Nicholson, Brian P. Hafler, Alessandro Sette, Shaughn H. Bryant, Edit Tarcsa, Donna McCarthy, Tariq Ghayur, Jijie Gu and Annette Schwartz and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Biotechnology and The Journal of Immunology.

In The Last Decade

Anwar Murtaza

13 papers receiving 560 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anwar Murtaza United States	9	296	284	258	153	31	13	596
Fabian Richter Germany	13	130 0.4×	213 0.8×	176 0.7×	129 0.8×	19 0.6×	23	455
Emanuel Calenoff United States	9	326 1.1×	209 0.7×	210 0.8×	189 1.2×	33 1.1×	17	570
Christine Grinnell United States	8	102 0.3×	295 1.0×	302 1.2×	99 0.6×	39 1.3×	12	490
Laura I. Salazar‐Fontana United States	8	312 1.1×	149 0.5×	80 0.3×	93 0.6×	12 0.4×	10	499
Heidi H. van Ojik Netherlands	9	322 1.1×	245 0.9×	325 1.3×	263 1.7×	23 0.7×	11	620
Yasuo Sekimori Japan	4	116 0.4×	250 0.9×	240 0.9×	96 0.6×	8 0.3×	6	382
H J Schluesener Germany	7	307 1.0×	140 0.5×	67 0.3×	103 0.7×	51 1.6×	7	489
S. Maloney Canada	12	114 0.4×	193 0.7×	111 0.4×	114 0.7×	18 0.6×	32	528
Felipe Vences‐Catalán United States	12	235 0.8×	228 0.8×	46 0.2×	110 0.7×	21 0.7×	17	505
Lourdes Places Spain	16	455 1.5×	182 0.6×	127 0.5×	108 0.7×	46 1.5×	33	685

Countries citing papers authored by Anwar Murtaza

Since Specialization

Citations

This map shows the geographic impact of Anwar Murtaza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anwar Murtaza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anwar Murtaza more than expected).

Fields of papers citing papers by Anwar Murtaza

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anwar Murtaza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anwar Murtaza. The network helps show where Anwar Murtaza may publish in the future.

Co-authorship network of co-authors of Anwar Murtaza

This figure shows the co-authorship network connecting the top 25 collaborators of Anwar Murtaza. A scholar is included among the top collaborators of Anwar Murtaza based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anwar Murtaza. Anwar Murtaza is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Shen, Chen, Ming Qiu, Nanni Huser, et al.. (2024). Abstract 5709: PF-07104091, a first-in-class CDK2-selective inhibitor for the treatment of HR+/HER2- breast cancer and CCNE1high ovarian cancer. Cancer Research. 84(6_Supplement). 5709–5709. 6 indexed citations

Degnan, Andrew P., Walter L. Johnson, Kurt Zimmermann, et al.. (2021). Discovery of Orally Active Isofuranones as Potent, Selective Inhibitors of Hematopoetic Progenitor Kinase 1. ACS Medicinal Chemistry Letters. 12(3). 443–450. 36 indexed citations

Parrish, Karen E., Lihong Cheng, Paul Stetsko, et al.. (2020). Pharmacodynamics‐based approach for efficacious human dose projection of BMS‐986260, a small molecule transforming growth factor beta receptor 1 inhibitor. Biopharmaceutics & Drug Disposition. 42(4). 137–149. 2 indexed citations

Zhao, Qihong, Anwar Murtaza, Ragini Vuppugalla, et al.. (2018). Abstract 3760: Preclinical antitumor activity of a CC chemokine receptor (CCR) 2/5 dual antagonist as monotherapy and in combination with immune checkpoint blockade. Cancer Research. 78(13_Supplement). 3760–3760. 8 indexed citations

Sevilla, Raquel, Shuli Zhang, Chi‐Sung Chiu, et al.. (2014). Etanercept ameliorates inflammation and pain in a novel mono-arthritic multi-flare model of streptococcal cell wall induced arthritis. BMC Musculoskeletal Disorders. 15(1). 409–409. 9 indexed citations

Li, Jinhe, Richard Harris, Jianguo Ji, et al.. (2011). Role of α7 nicotinic acetylcholine receptors in regulating tumor necrosis factor-α (TNF-α) as revealed by subtype selective agonists. Journal of Neuroimmunology. 239(1-2). 37–43. 29 indexed citations

Li, Jinhe, Richard Harris, Jianguo Ji, et al.. (2009). Role of α7 nicotinic acetylcholine receptors in regulating tumor necrosis factor-α (TNF-α) as Revealed by subtype selective agonists. Biochemical Pharmacology. 78(7). 924–925. 2 indexed citations

Bardwell, Philip D., Jijie Gu, Donna McCarthy, et al.. (2009). The Bcl-2 Family Antagonist ABT-737 Significantly Inhibits Multiple Animal Models of Autoimmunity. The Journal of Immunology. 182(12). 7482–7489. 59 indexed citations

Wu, Chengbin, Ying Hua, Christine Grinnell, et al.. (2007). Simultaneous targeting of multiple disease mediators by a dual-variable-domain immunoglobulin. Nature Biotechnology. 25(11). 1290–1297. 253 indexed citations

10.

Murtaza, Anwar, Pankaj Tailor, Valérie C. Asensio, et al.. (2001). Altered functional and biochemical response by CD8+ T cells that remain after tolerance. International Immunology. 13(8). 1085–1093. 5 indexed citations

11.

Sherman, Linda A., David J. Morgan, Javier Hernández, et al.. (2000). Self-Tolerance and the Composition of T Cell Repertoire. Immunologic Research. 21(2-3). 305–314. 12 indexed citations

12.

Murtaza, Anwar, Vijay K. Kuchroo, & Gordon J. Freeman. (1999). Changes in the strength of co-stimulation through the B7/CD28 pathway alter functional T cell responses to altered peptide ligands. International Immunology. 11(3). 407–416. 34 indexed citations

13.

Nicholson, Lindsay B., Anwar Murtaza, Brian P. Hafler, Alessandro Sette, & Vijay K. Kuchroo. (1997). A T cell receptor antagonist peptide induces T cells that mediate bystander suppression and prevent autoimmune encephalomyelitis induced with multiple myelin antigens. Proceedings of the National Academy of Sciences. 94(17). 9279–9284. 141 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact